The magic of the technology behind Disney: How guests are becoming the heroes in their own stories

03/01/22 • 30 min

Learn how Disney is utilizing technology to enhance the customer experience with new initiatives and how the Disney accelerator is creating new entertainment adventures and products. Kathy de Paolo, Vice President of Engineering at The Walt Disney Company, shares all this and entrepreneurial advice for all.
Links:
Kathy’s LinkedIn profile
Walt Disney Imagineering: https://sites.disney.com/waltdisneyimagineering/
Disney: https://www.disney.com/
Disney Accelerator: https://disneyaccelerator.com/
Host: Brett Malone
Editor and Producer: Becca Halm

Previous Episode

The art of partnering: How your small company can change the game for big companies

Kenna Anderes Ph.D., RAC, Vice President of Translational Medicine & Companion Diagnostics at Mirati Therapeutics, talks → The art of partnering: How your small company can change the game for big companies; plus, “FIO” Figure it Out, how to follow the data, and navigate complex timelines and more.

Dr. Anderes has been a scientific leader in oncology drug discovery, biomarker identification, and early clinical development in the pharmaceutical and biotech industries for over 20 years. She is trained as a pharmacologist and cancer biologist and has held a number of senior executive and scientific advisory positions at pharmaceutical, biotech, and in vitro diagnostic companies.
As an early employee in several startup companies, Dr. Anderes acquired very broad, interdisciplinary technical and business skills, with breadth in science, clinical research, clinical operations, regulatory strategy, and product/medical device development. Achievements range from lead identification of novel small molecule or biological entities to characterization of clinical development candidates for several distinct first-in-class molecular targeted agents to treat cancer. She has extensive experience directing and designing studies to determine relationships to drug exposure, mechanism of action, efficacy, and biomarkers in the single-agent and combination settings in vitro and in vivo in classical xenografts and patient-derived tumor models. In parallel to drug discovery/development activities,
Dr. Anderes has led equally diverse biomarker and in vitro diagnostic projects. She has evaluated numerous liquid biopsy approaches and served as an advisor on pharma-sponsored clinical trials to evaluate the clinical utility of CTCs and ctDNA. Delivery on the promise of personalized medicine requires strategic and tactical translational medicine expertise, Dr. Anderes formed Translational Medicine Partners, Inc. and co-founded Wild Type Advisors, LLC to provide bespoke consulting services for the life sciences, biotechnology and pharmaceutical industries.
Host: Brett Malone
Editor and Producer: Becca Halm

Next Episode

Tips on building your company, pivoting, and raising capital

Learn more about entrepreneurship and how to know you've hit traction with your startup from Active Capital Founder and CEO, Pat Matthews.
Pat is the founder and general partner of Active Capital, a venture firm focused on leading seed rounds for B2B SaaS companies outside of Silicon Valley. Prior to Active Capital, Pat was an entrepreneur, operator, and angel investor. Pat’s career started in 1999 when he dropped out of Virginia Tech to start a dot-com with some of his best friends and college roommates. After the dot-com bubble burst, Pat and his team persevered through years of economic downturn before creating Webmail.us, a $10 million dollar software company that was recognized as one of the fastest-growing private companies in America by Inc. Magazine. In 2007, Webmail.us was acquired by Rackspace where Pat worked as an executive on the senior leadership team until 2013. Pat has personally invested in nearly 100 startups and is an active board member of the Virginia Tech Apex Center for Entrepreneurship, Venture for America in San Antonio, and several Active Capital portfolio companies.
Host: Brett Malone
Editor and Producer: Becca Halm